|Project||Cost||Real world outcome||Outcome estimates||Economic value in Western terms||Leverage Factor|
|Case finding and treatment||$15||1 DALY saved||-||$90,000||6,000|
|Eflornithine for second stage treatment||$20||1 DALY saved||Sub-Saharan Africa target population||$90,000||4,500|
|Melarsoprol for second stage treatment||$10||1 DALY saved||Sub-Saharan Africa target population||$90,000||9,000|
We focus on identification and the primary stage of the disease, and do not incorporate the second stage treatment into the Leverage Factor.